These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36398426)

  • 1. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
    Hlophe YN; Joubert AM
    J Cell Mol Med; 2022 Dec; 26(23):5743-5754. PubMed ID: 36398426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
    Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
    Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
    Spinella F; Caprara V; Di Castro V; Rosanò L; Cianfrocca R; Natali PG; Bagnato A
    J Mol Med (Berl); 2013 Mar; 91(3):395-405. PubMed ID: 22965194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.
    Abedi H; Zachary I
    J Biol Chem; 1997 Jun; 272(24):15442-51. PubMed ID: 9182576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the VEGF-C/VEGFR-3 axis in cancer progression.
    Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML
    Br J Cancer; 2007 Feb; 96(4):541-5. PubMed ID: 17164762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes.
    Igarashi Y; Chosa N; Sawada S; Kondo H; Yaegashi T; Ishisaki A
    Int J Mol Med; 2016 Apr; 37(4):1005-13. PubMed ID: 26934950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
    Coso S; Zeng Y; Opeskin K; Williams ED
    PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome.
    Zhang L; Ye C; Li P; Li C; Shu W; Zhao Y; Wang X
    Stem Cell Res Ther; 2022 Sep; 13(1):448. PubMed ID: 36064450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
    Chen H; Suo K; Cheng Y; Zheng B; Xu L
    Gynecol Endocrinol; 2013 Jan; 29(1):20-4. PubMed ID: 22817694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
    Iwami D; Brinkman CC; Bromberg JS
    Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.
    Ganju RK; Brubaker SA; Meyer J; Dutt P; Yang Y; Qin S; Newman W; Groopman JE
    J Biol Chem; 1998 Sep; 273(36):23169-75. PubMed ID: 9722546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor.
    Liao WX; Feng L; Zheng J; Chen DB
    Endocrinology; 2010 Jul; 151(7):3432-44. PubMed ID: 20463056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.
    Han KY; Chang JH; Dugas-Ford J; Alexander JS; Azar DT
    FEBS Lett; 2014 Nov; 588(23):4357-63. PubMed ID: 25281926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.